Experiments with mice have revealed that Krt19+/Lgr5−cells are radioresistant cancer-initiating stem cells in the colon and intestine (Asfaha et al. 2015), which can partially explain the poorer prognosis of tumors with higher KRT19 expression. This evidence concerns the gene KRT19 and cancer.